{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:20:27Z","timestamp":1787170827839,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jacbts.2018.08.011","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T16:20:04Z","timestamp":1546273204000},"page":"796-809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Hydrogen Sulfide Attenuates Renin\u00a0Angiotensin and Aldosterone Pathological Signaling to Preserve Kidney\u00a0Function and Improve Exercise\u00a0Tolerance in Heart Failure"],"prefix":"10.1016","volume":"3","author":[{"given":"Zhen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea L.","family":"Organ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Polhemus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi K.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Thomas E.","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack S.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-xiong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Lefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2018.08.011_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/clc.22260","article-title":"A\u00a0reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States","volume":"37","author":"Voigt","year":"2014","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.30","article-title":"Co-morbidities in patients with heart failure: an analysis of the European heart failure pilot survey","volume":"16","author":"van Deursen","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2018.08.011_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-012-9370-7","article-title":"Co-morbidities in heart failure","volume":"19","author":"van Deursen","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacbts.2018.08.011_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hfc.2013.12.003","article-title":"Cardiorenal syndrome","volume":"10","author":"Ronco","year":"2014","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.jacbts.2018.08.011_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijcard.2012.04.106","article-title":"Mending injured endothelium in chronic heart failure: a new target for exercise training","volume":"166","author":"Van Craenenbroeck","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1566-0702(01)00270-3","article-title":"Autonomic dysregulation in essential hypertension: insight from heart rate and arterial pressure variability","volume":"90","author":"Pagani","year":"2001","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.jacbts.2018.08.011_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40292-017-0194-3","article-title":"Current pharmacological therapies in heart failure patients","volume":"24","author":"Muiesan","year":"2017","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.jacbts.2018.08.011_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10253890802046281","article-title":"Stress, depression and\u00a0cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models","volume":"12","author":"Grippo","year":"2009","journal-title":"Stress"},{"key":"10.1016\/j.jacbts.2018.08.011_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neubiorev.2008.07.004","article-title":"Mechanisms underlying altered mood and cardiovascular dysfunction: the value of neurobiological and behavioral research with animal models","volume":"33","author":"Grippo","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jacbts.2018.08.011_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/B:HREV.0000046363.59374.23","article-title":"Biologic rationale for the use of beta-blockers in the treatment of heart failure","volume":"9","author":"Sabbah","year":"2004","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacbts.2018.08.011_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11906-011-0200-4","article-title":"Sympathetic mechanisms, organ damage, and antihypertensive treatment","volume":"13","author":"Grassi","year":"2011","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacbts.2018.08.011_bib13","doi-asserted-by":"crossref","first-page":"134S","DOI":"10.1016\/j.amjhyper.2005.05.005","article-title":"How to explain the differences between renin angiotensin system modulators","volume":"18","author":"Levy","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacbts.2018.08.011_bib14","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jacc.2017.08.056","article-title":"Renal sympathetic denervation protects the failing heart via inhibition of neprilysin activity in the kidney","volume":"70","author":"Polhemus","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib15","first-page":"194910","article-title":"Therapeutic options for the management of the cardiorenal syndrome","volume":"2011","author":"Koniari","year":"2010","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/CIRCRESAHA.114.300505","article-title":"Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease","volume":"114","author":"Polhemus","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2018.08.011_bib17","doi-asserted-by":"crossref","first-page":"768607","DOI":"10.1155\/2014\/768607","article-title":"The cardioprotective actions of hydrogen sulfide in\u00a0acute myocardial infarction and heart failure","volume":"2014","author":"Polhemus","year":"2014","journal-title":"Scientifica"},{"key":"10.1016\/j.jacbts.2018.08.011_bib18","doi-asserted-by":"crossref","first-page":"H2410","DOI":"10.1152\/ajpheart.00044.2012","article-title":"The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability","volume":"302","author":"Predmore","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib19","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/CIRCHEARTFAILURE.113.000299","article-title":"Hydrogen sulfide attenuates cardiac dysfunction after heart failure via induction of angiogenesis","volume":"6","author":"Polhemus","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2018.08.011_bib20","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1021\/jacs.6b01373","article-title":"pH-Controlled hydrogen sulfide release for myocardial ischemia-reperfusion injury","volume":"138","author":"Kang","year":"2016","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.jacbts.2018.08.011_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12265-010-9201-y","article-title":"Development of hydrogen sulfide-based therapeutics for cardiovascular disease","volume":"3","author":"Predmore","year":"2010","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jacbts.2018.08.011_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.phrs.2016.06.029","article-title":"Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide","volume":"111","author":"Zhou","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacbts.2018.08.011_bib23","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/bph.12811","article-title":"The role of gasotransmitters NO, H2S and CO in myocardial ischaemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning","volume":"172","author":"Andreadou","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fphar.2016.00385","article-title":"The role of hydrogen sulfide in renal system","volume":"7","author":"Cao","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib25","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCULATIONAHA.112.000855","article-title":"H(2)S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase","volume":"127","author":"Kondo","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2018.08.011_bib26","doi-asserted-by":"crossref","first-page":"H311","DOI":"10.1152\/ajpheart.00515.2017","article-title":"A\u00a0novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure","volume":"314","author":"Bradley","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"10.1016\/j.jacbts.2018.08.011_bib27","article-title":"Combined angiotensin receptor-neprilysin inhibitors improve cardiac and vascular function via increased no bioavailability in heart failure","volume":"7","author":"Trivedi","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2018.08.011_bib28","doi-asserted-by":"crossref","first-page":"H842","DOI":"10.1152\/ajpheart.00455.2016","article-title":"Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure","volume":"312","author":"Sung","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1755-5922.12128","article-title":"A\u00a0novel hydrogen sulfide prodrug, SG1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients","volume":"33","author":"Polhemus","year":"2015","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jacbts.2018.08.011_bib30","doi-asserted-by":"crossref","first-page":"e002368","DOI":"10.1161\/CIRCHEARTFAILURE.115.002368","article-title":"Sodium sulfide attenuates ischemic-induced heart failure by enhancing proteasomal function in an Nrf2-dependent manner","volume":"9","author":"Shimizu","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacbts.2018.08.011_bib31","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1073\/pnas.1321871111","article-title":"Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent","volume":"111","author":"King","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2018.08.011_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.phrs.2016.08.026","article-title":"Regulation and role of endogenously produced hydrogen sulfide in angiogenesis","volume":"113","author":"Katsouda","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacbts.2018.08.011_bib33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/mol.117.109645","article-title":"Hydrogen sulfide preserves endothelial nitric oxide synthase function by inhibiting proline-rich kinase 2: implications for cardiomyocyte survival and cardioprotection","volume":"92","author":"Bibli","year":"2017","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.jacbts.2018.08.011_bib34","article-title":"Hydrogen sulfide levels and nuclear factor-erythroid 2-related factor 2 (NRF2) activity are attenuated in the setting of critical limb ischemia (CLI)","volume":"4","author":"Islam","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2018.08.011_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ahj.2004.02.007","article-title":"Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival","volume":"148","author":"Smilde","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacbts.2018.08.011_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCRESAHA.109.199919","article-title":"Hydrogen sulfide mediates cardioprotection through Nrf2 signaling","volume":"105","author":"Calvert","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2018.08.011_bib37","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/bph.13861","article-title":"Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner","volume":"175","author":"Meng","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.118.311134","article-title":"Evolution of hydrogen sulfide therapeutics to treat cardiovascular disease","volume":"123","author":"Li","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2018.08.011_bib39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1681\/ASN.2015080852","article-title":"G\u00a0protein-coupled receptor-G-protein betagamma-subunit signaling mediates renal dysfunction and fibrosis in heart failure","volume":"28","author":"Kamal","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib40","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/HYPERTENSIONAHA.117.09123","article-title":"Selective Nrf2 gene deletion in the rostral ventrolateral medulla evokes hypertension and sympathoexcitation in mice","volume":"69","author":"Gao","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2018.08.011_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/ars.2012.5024","article-title":"Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetes","volume":"19","author":"Xue","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jacbts.2018.08.011_bib42","doi-asserted-by":"crossref","first-page":"2715718","DOI":"10.1155\/2016\/2715718","article-title":"Hydrogen sulfide mitigates kidney injury in high fat diet-induced obese mice","volume":"2016","author":"Wu","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jacbts.2018.08.011_bib43","doi-asserted-by":"crossref","first-page":"H874","DOI":"10.1152\/ajpheart.00637.2016","article-title":"Hydrogen sulfide alleviates hypertensive kidney dysfunction through an epigenetic mechanism","volume":"312","author":"Weber","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib44","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1038\/s41598-017-11256-3","article-title":"GYY4137, a hydrogen sulfide donor modulates miR194-dependent collagen realignment in diabetic kidney","volume":"7","author":"John","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2018.08.011_bib45","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/nau.22450","article-title":"Exogenous hydrogen sulfide prevents kidney damage following unilateral ureteral obstruction","volume":"33","author":"Jiang","year":"2014","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"10.1016\/j.jacbts.2018.08.011_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19051438","article-title":"Hydrogen Sulfide in hypertension and kidney disease of developmental origins","volume":"19","author":"Hsu","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacbts.2018.08.011_bib47","doi-asserted-by":"crossref","first-page":"7570489","DOI":"10.1155\/2016\/7570489","article-title":"Protective effects of hydrogen sulfide in the ageing kidney","volume":"2016","author":"Hou","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jacbts.2018.08.011_bib48","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/HJR.0b013e3283361dc5","article-title":"Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I","volume":"17","author":"Piepoli","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jacbts.2018.08.011_bib49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/HJR.0b013e32833f3aa5","article-title":"Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II","volume":"17","author":"Piepoli","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.jacbts.2018.08.011_bib50","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1161\/CIRCULATIONAHA.116.022967","article-title":"Restoration of hydrogen sulfide production in\u00a0diabetic mice improves reparative function of\u00a0bone\u00a0marrow cells","volume":"134","author":"Cheng","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2018.08.011_bib51","doi-asserted-by":"crossref","first-page":"C537","DOI":"10.1152\/ajpcell.00329.2016","article-title":"Vascular biology of hydrogen sulfide","volume":"312","author":"Kanagy","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib52","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2009.11.086","article-title":"Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors","volume":"55","author":"Esposito","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib53","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","article-title":"Endothelial dysfunction, arterial stiffness, and heart failure","volume":"60","author":"Marti","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2018.08.011_bib54","doi-asserted-by":"crossref","first-page":"11299","DOI":"10.1073\/pnas.92.24.11299","article-title":"Nitric oxide inhibits the release of norepinephrine and dopamine from the medial basal hypothalamus of the rat","volume":"92","author":"Seilicovich","year":"1995","journal-title":"Proc Natl Acad Sci U S A"}],"updated-by":[{"DOI":"10.1016\/j.jacbts.2019.01.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000}}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X18302377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X18302377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T10:00:47Z","timestamp":1611568847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X18302377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2452302X18302377"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2018.08.011","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogen Sulfide Attenuates Renin\u00a0Angiotensin and Aldosterone Pathological Signaling to Preserve Kidney\u00a0Function and Improve Exercise\u00a0Tolerance in Heart Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2018.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}